262 related articles for article (PubMed ID: 23930950)
1. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.
Ouwehand AC; ten Bruggencate SJ; Schonewille AJ; Alhoniemi E; Forssten SD; Bovee-Oudenhoven IM
Br J Nutr; 2014 Feb; 111(3):465-73. PubMed ID: 23930950
[TBL] [Abstract][Full Text] [Related]
2. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
Ten Bruggencate SJ; Girard SA; Floris-Vollenbroek EG; Bhardwaj R; Tompkins TA
Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
McKenzie R; Bourgeois AL; Engstrom F; Hall E; Chang HS; Gomes JG; Kyle JL; Cassels F; Turner AK; Randall R; Darsley M; Lee C; Bedford P; Shimko J; Sack DA
Infect Immun; 2006 Feb; 74(2):994-1000. PubMed ID: 16428745
[TBL] [Abstract][Full Text] [Related]
6. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.
Darsley MJ; Chakraborty S; DeNearing B; Sack DA; Feller A; Buchwaldt C; Bourgeois AL; Walker R; Harro CD
Clin Vaccine Immunol; 2012 Dec; 19(12):1921-31. PubMed ID: 23035175
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
Ruan X; Zhang W
Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a single oral dose of a live bivalent E. coli vaccine against post-weaning diarrhea due to F4 and F18-positive enterotoxigenic E. coli.
Nadeau É; Fairbrother JM; Zentek J; Bélanger L; Tremblay D; Tremblay CL; Röhe I; Vahjen W; Brunelle M; Hellmann K; Cvejić D; Brunner B; Schneider C; Bauer K; Wolf R; Hidalgo Á
Vet J; 2017 Aug; 226():32-39. PubMed ID: 28911838
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
10. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
[TBL] [Abstract][Full Text] [Related]
12. Effect of crowding stress and Escherichia coli K88+ challenge in nursery pigs supplemented with anti-Escherichia coli K88+ probiotics.
Khafipour E; Munyaka PM; Nyachoti CM; Krause DO; Rodriguez-Lecompte JC
J Anim Sci; 2014 May; 92(5):2017-29. PubMed ID: 24663172
[TBL] [Abstract][Full Text] [Related]
13. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of a vaccine candidate expressing enterotoxigenic Escherichia coli (ETEC) adhesins for colibacillosis with a commercial vaccine using a pig model.
Hur J; Lee JH
Vaccine; 2012 Jun; 30(26):3829-33. PubMed ID: 22507658
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
[TBL] [Abstract][Full Text] [Related]
16. C57-CD40 ligand deficient mice: a potential model for enterotoxigenic Escherichia coli (H10407) colonization.
Bernal-Reynaga R; Thompson-Bonilla R; Lopez-Saucedo C; Pech-Armenta M; Estrada-Parra S; Estrada-Garcia T
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):50-6. PubMed ID: 23098671
[TBL] [Abstract][Full Text] [Related]
17. Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.
Harro C; Chakraborty S; Feller A; DeNearing B; Cage A; Ram M; Lundgren A; Svennerholm AM; Bourgeois AL; Walker RI; Sack DA
Clin Vaccine Immunol; 2011 Oct; 18(10):1719-27. PubMed ID: 21852546
[TBL] [Abstract][Full Text] [Related]
18. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters.
Ouwehand AC; Tiihonen K; Saarinen M; Putaala H; Rautonen N
Br J Nutr; 2009 Feb; 101(3):367-75. PubMed ID: 18634707
[TBL] [Abstract][Full Text] [Related]
19. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
Tobias J; Svennerholm AM
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
[TBL] [Abstract][Full Text] [Related]
20. Novel vaccine-adjuvant combination successful against bacterial diarrhea.
Hum Vaccin Immunother; 2014; 10(12):3428. PubMed ID: 26052587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
